Logo image
Back
Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study
Journal article   Open access   Peer reviewed

Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study

Jordan W Smoller, Matthew Allison, Barbara B Cochrane, J David Curb, Roy H Perlis, Jennifer G Robinson, Milagros C Rosal, Nanette K Wenger and Sylvia Wassertheil-Smoller
Archives of internal medicine (1960), Vol.169(22), pp.2128-2139
12/14/2009
DOI: 10.1001/archinternmed.2009.436
PMID: 20008698
url
https://doi.org/10.1001/archinternmed.2009.436View
Published (Version of record) Open Access

Abstract

Antidepressants are commonly prescribed medications, but their effect on cardiovascular morbidity and mortality remains unclear. Prospective cohort study of 136 293 community-dwelling postmenopausal women in the Women's Health Initiative (WHI). Women taking no antidepressants at study entry and who had at least 1 follow-up visit were included. Cardiovascular morbidity and all-cause mortality for women with new antidepressant use at follow-up (n = 5496) were compared with those characteristics for women taking no antidepressants at follow-up (mean follow-up, 5.9 years). Antidepressant use was not associated with coronary heart disease (CHD). Selective serotonin reuptake inhibitor (SSRI) use was associated with increased stroke risk (hazard ratio [HR],1.45, [95% CI, 1.08-1.97]) and all-cause mortality (HR,1.32 [95% CI, 1.10-1.59]). Annualized rates per 1000 person-years of stroke with no antidepressant use and SSRI use were 2.99 and 4.16, respectively, and death rates were 7.79 and 12.77. Tricyclic antidepressant (TCA) use was associated with increased risk of all-cause mortality (HR,1.67 [95% CI, 1.33-2.09]; annualized rate, 14.14 deaths per 1000 person-years). There were no significant differences between SSRI and TCA use in risk of any outcomes. In analyses by stroke type, SSRI use was associated with incident hemorrhagic stroke (HR, 2.12 [95% CI, 1.10-4.07]) and fatal stroke (HR, 2.10 [95% CI, 1.15-3.81]). In postmenopausal women, there were no significant differences between SSRI and TCA use in risk of CHD, stroke, or mortality. Antidepressants were not associated with risk of CHD. Tricyclic antidepressants and SSRIs may be associated with increased risk of mortality, and SSRIs with increased risk of hemorrhagic and fatal stroke, although absolute event risks are low. These findings must be weighed against quality of life and established risks of cardiovascular disease and mortality associated with untreated depression.
 Cardiovascular Diseases - etiology Prospective Studies Women's Health Humans Middle Aged Risk Factors Cardiovascular Diseases - epidemiology Postmenopause Female Aged Antidepressive Agents - adverse effects Incidence

Details

Metrics

30 Record Views
194 Times Cited - Web of Science
Logo image